Researcher Profile

Researcher Profile

Yulong Li, MD, MS

Yulong Li, MD, MS

Assistant Professor, Department of Medicine
Division of Endocrinology and Diabetes
Assistant Professor, Department of Biochemistry and Molecular Biology
Scientific Program:Mechanisms of Carcinogenesis
yul576@psu.edu

Research Interests

  • Hyperparathyroidism 1
  • Hyperparathyroidism 3
  • Primary Hyperparathyroidism
  • Mutation
  • Germ-Line Mutation
  • Pheochromocytoma
  • Human Herpesvirus 4
  • Coinfection
  • Cytomegalovirus
  • Hyperparathyroidism
  • Lung
  • Neoplasms

Recent Publications

2018

El Lakis, M, Nockel, P, Guan, B, Agarwal, S, Welch, J, Simonds, WF, Marx, S, Li, Y, Nilubol, N, Patel, D, Yang, L, Merkel, R & Kebebew, E 2018, 'Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cure', Surgery (United States), vol. 163, no. 1, pp. 31-34. https://doi.org/10.1016/j.surg.2017.04.027

2017

Guan, B, Welch, JM, Vemulapalli, M, Li, Y, Ling, H, Kebebew, E, Simonds, WF, Marx, SJ & Agarwal, SK 2017, 'Ethnicity of Patients With Germline GCM2-Activating Variants and Primary Hyperparathyroidism' Journal of the Endocrine Society, vol. 1, no. 5, pp. 488-499.
Li, Y & Simonds, WF 2017, 'Recent advances in the management of endocrine malignancies associated with hereditary hyperparathyroidism syndromes' International Journal of Endocrine Oncology, vol. 4, no. 2. https://doi.org/10.2217/ije-2016-0018

2016

Li, Y & Simonds, WF 2016, 'Endocrine neoplasms in familial syndromes of hyperparathyroidism', Endocrine-Related Cancer, vol. 23, no. 6, pp. R229-R247. https://doi.org/10.1530/ERC-16-0059
Guan, B, Welch, JM, Sapp, JC, Ling, H, Li, Y, Johnston, JJ, Kebebew, E, Biesecker, LG, Simonds, WF, Marx, SJ & Agarwal, SK 2016, 'GCM2-Activating Mutations in Familial Isolated Hyperparathyroidism', American Journal of Human Genetics, vol. 99, no. 5, pp. 1034-1044. https://doi.org/10.1016/j.ajhg.2016.08.018

Clinical Trials Search


Children (age < 18 years)
Adults (age >= 18 years)